The New England Journal of Medicine (NEJM) recently published several articles about some technology advances in the care of patients with diabetes. Those articles are:
- Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
- Continuous Glucose Monitoring — Coming of Age
We're probably going to see an increase in the use of continuous glucose monitors among patients with either type 1 or type 2 diabetes. Will this eventually become the "standard of care?" Right now, many people are unable to afford continuous glucose monitors and sensor-augmented pumps. How will this change over the next decade? Perhaps the biggest question is: who's going to pay for this expensive technology? If you're on the government-sponsored "public option" insurance plan, will you get coverage for this type of technology?